So sánh phương pháp

	Craig Handicap Assessment and Reporting Technique	Tác động đến sự tham gia và quyền tự quyết
Lĩnh vực	Khoa học phục hồi chức năng	Khoa học phục hồi chức năng
Họ	Process / pipeline	Process / pipeline
Năm ra đời	1992	2001
Người khởi xướng	Whiteneck, Charlifue, Gerhart, Overholser, Richardson	Cardol, de Haan, de Groot, de Jong
Loại	Interview or Self-report	Self-report or Proxy
Công trình gốc	Whiteneck, G. G., Charlifue, S. W., Gerhart, K. A., Overholser, J. D., & Richardson, G. N. (1992). Quantifying handicap: a new measure of long-term rehabilitation outcomes. Archives of Physical Medicine and Rehabilitation, 73(6), 519–526.	Cardol, M., de Haan, R. J., de Jong, B. A., van den Bos, G. A., & de Groot, I. J. (2001). Psychometric properties of the Impact on Participation and Autonomy questionnaire. Archives of Physical Medicine and Rehabilitation, 82(2), 210–216.
Tên gọi khác	CHART, CHART-SF	IPA, IPA-Scale
Liên quan	5	5
Tóm tắt	The Craig Handicap Assessment and Reporting Technique (CHART) is a comprehensive interview-based measure designed to quantify how much a disabling condition restricts participation in six key social roles: physical independence, mobility, occupation, social integration, economic self-sufficiency, and cognitive independence. Developed by Whiteneck and colleagues at the Craig Hospital (now national leader in spinal cord injury care), CHART has become the gold-standard outcome measure for long-term spinal cord injury and traumatic brain injury follow-up, extensively used in international outcomes research.	The Impact on Participation and Autonomy (IPA) scale is a validated, patient-centered measure designed to quantify how chronic conditions or disabilities affect an individual's autonomy and participation in five key life domains: autonomy, mobility, occupation, social relations, and recreation. Developed in the Netherlands by Cardol and colleagues, it operationalizes the WHO handicap concept (now called 'participation restriction') and is widely used in rehabilitation, chronic disease management, and policy evaluation across Europe.